Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Genky Drug Stores Co's quarterly market cap
declined
from Sep. 2025 (円152,932 Mil) to Dec. 2025 (円151,176 Mil) and
declined
from Dec. 2025 (円151,176 Mil) to Mar. 2026 (円120,697 Mil).
Genky Drug Stores Co's annual market cap
increased
from Jun. 2024 (円87,567 Mil) to Jun. 2025 (円115,961 Mil) but then
declined
from Jun. 2025 (円115,961 Mil) to Jun. 2026 (円102,867 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Genky Drug Stores Co's Enterprise Value for Today is 円143,480 Mil.
Genky Drug Stores Co (TSE:9267) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Genky Drug Stores Co Market Cap Related Terms
Genky Drug Stores Co Market Cap Historical Data
* Premium members only.
The historical data trend for Genky Drug Stores Co's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genky Drug Stores Co Market Cap Competitor Comparison
For the Pharmaceutical Retailers subindustry, Genky Drug Stores Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genky Drug Stores Co Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Genky Drug Stores Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Genky Drug Stores Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Genky Drug Stores Co's Market Cap for the fiscal year that ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genky Drug Stores Co (TSE:9267) has a Market Cap of 円111,706 Mil as of Sep. 07, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Genky Drug Stores Co and its competitors. According to the industry distribution chart, Genky Drug Stores Co ranks #163 out of 692 companies in the Healthcare Providers & Services industry, placing it in the top 23.6%.
Is Genky Drug Stores Co's Market Cap too high?
Genky Drug Stores Co's current Market Cap is 円111,706 Mil. Based on the distribution chart, Genky Drug Stores Co ranks #163 out of 692 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Genky Drug Stores Co has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Genky Drug Stores Co's Market Cap compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Genky Drug Stores Co ranks #163 out of 692 companies for Market Cap. This places Genky Drug Stores Co in the top 24% of its industry — outperforming the majority of peers. The industry median Market Cap is 109.45. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 109.45, based on 692 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Genky Drug Stores Co and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 109.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genky Drug Stores Co's current Market Cap is 円111,706 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genky Drug Stores Co stock overvalued right now?
Based on GuruFocus' analysis, Genky Drug Stores Co (TSE:9267) is currently considered Fairly Valued. The stock's GF Value™ is 円3,790.79, compared to a current price of 円3,665.00 — trading 3.3% below its estimated fair value. The current Market Cap is 円111,706 Mil. Genky Drug Stores Co's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Genky Drug Stores Co (TSE:9267), the current Market Cap is 円111,706 Mil as of Sep. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Genky Drug Stores Co (TSE:9267) Overvalued in 2026?
Based on GuruFocus' analysis, Genky Drug Stores Co stock appears to be undervalued.
The current stock price of 円3,665.00 is trading 3.3% below its estimated GF Value™ of 円3,790.79.
GuruFocus considers Genky Drug Stores Co to be Fairly Valued.
Key valuation signals for TSE:9267:
Market Cap: 円111,706 Mil
GF Value™: 円3,790.79 vs. price of 円3,665.00 (3.3% below fair value)
No single metric tells the full story. See the TSE:9267 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:9267 has been successfully added to your 
